Abstract
Background: In the literature, suggested strategies for the follow-up of colon cancer patients after potentially curative resections vary widely. The optimal regimen to monitor for recurrences and new primary tumors remains unknown. The nationwide cost impact of wide practice variation is also unknown.
Methods: The 1,070 members of The Society of Surgical Oncology (SSO) were surveyed using a detailed questionnaire to measure the practice patterns of surgical experts nationwide. Respondents were asked how often they use nine separate methodologies in follow-up during years 1–5 postsurgery for TNM stage I, II, and III patients. Costs were estimated for representative less and more intensive strategies.
Results: Evaluable responses were received from 349 members (33%). Office visit and carcinoembryonic antigen analysis were performed most frequently. SSO members generally see patients every 3 months in years 1–2, every 6 months in years 3–4, and annually thereafter. There was wide variability in test ordering patterns and moderate variation between SSO and previously surveyed American Society of Colon and Rectal Surgeons members. The charge differential between representative less and more intensive follow-up strategies for each annual U.S. patient cohort is ∼$800 million.
Conclusions: Actual practice patterns vary widely, indicating lack of consensus regarding optimal follow-up. The enormous cost differential associated with such variation is difficult to justify because there is no proven benefit of more intensive follow-up.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Stevenson GW. Radiology and endoscopy in the pretreatment diagnostic management of colorectal cancer.Cancer 1993;71(suppl):4198–206.
Waye J, Lewis B, Yessayan S. Colonoscopy, a prospective report of complications.Gastrointest Endosc 1990;36:226.
Rocklin MS, Slomski CA, Watne AL. Postoperative surveillance of patients with carcinoma of the colon and rectum.Am Surgeon 1990;56:22–7.
Beart RW, Metzger PP, O'Connell MJ, Schutt AJ. Postoperative screening of patients with carcinoma of the colon.Dis Colon Rectum 1981;24:585–8.
Beart RW, O'Connell MJ. Postoperative follow-up of patients with carcinoma of the colon.Mayo Clin Proc 1983;58:361–3.
Steele G Jr. Follow-up plans after curative resection of primary colon or rectum cancer. In: Steele G, Osteen RT, eds.Colorectal cancer. New York: Marcel Dekker, 1986.
Steele G Jr. Follow-up plans after treatment of primary colon and rectum cancer.World J Surg 1991;15:583–8.
Patchett SE, Mulcahy HE, O'Donoghue DP. Colonoscopic surveillance after curative resection for colorectal cancer.Br J Surg 1993;80:1330–2.
Buie WD, Rothenberger DA. Surveillance after curative resection of colorectal cancer.Gastrointest Endosc Clin North Am 1993;3:691–713.
Devesa JM, Morales V, Enriquez JM, et al. Colorectal cancer: the bases for a comprehensive follow-up.Dis Colon Rectum 1988;31:636–52.
GIVIO Investigators. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial.JAMA 1994;271:1587–92.
Vernava AM, Longo WE, Virgo KS, Coplin MA, Wade TP, Johnson FE. Current follow-up strategies after resection of colon cancer: results of a survey of ASCRS members.Dis Colon Rectum 37:1994;573–83.
Fleischer DE, Goldberg SB, Browning TH, et al. Detection and surveillance of colorectal cancer.JAMA 1989;261:580.
Health Care Financing Administration. Part B Medicare Annual Data (BMAD) file, 1992.
Health Care Financing Administration. Medicare Hospital Outpatient Bill (HOP) file, 1992.
DeCosse JJ, Tsioulias GJ, Jacobson JS. Colorectal cancer: detection, treatment, and rehabilitation.CA 1994;44:27–42.
American Cancer Society.Cancer Facts & Figures—1993.
Miller BA, Ries LAG, Hankey BF, Kosary CL, Edwards BK, eds.Cancer Statistics Review: 1973–1989. Table VI-7, National Cancer Institute. NIH Publication No. 92-2789, 1992.
Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer.JAMA 1993;270:943–7.
Tornqvist A, Ekulund G, Leandoer L. The value of intensive follow-up after curative resection for colorectal carcinoma.Br J Surg 1982;69:725–8.
Ovaska J, Jarvinen H, Kujari H, Pertilla I, Mecklin JP. Follow-up of patients operated on for colorectal carcinoma.Am J Surg 1990;159:593–6.
Ovaska J, Jarvinen H, Kujari H, Pertilla I, Mecklin JP. Surveillance after colon cancer: is it worthwhile?Gastroenterology 1990;99:1849–51.
Wagner JS, Adson MA, van Heerden JA, Adson MH, Ilstrup DM. The natural history of hepatic metastases from colorectal cancer.Ann Surg 1984;199:512–8.
Author information
Authors and Affiliations
Additional information
The views expressed in this paper are those of the authors and should not be construed to reflect the official position of either St. Louis University or the Department of Veterans Affairs.
Rights and permissions
About this article
Cite this article
Virgo, K.S., Wade, T.P., Longo, W.E. et al. Surveillance after curative colon cancer resection: Practice patterns of surgical subspecialists. Annals of Surgical Oncology 2, 472–482 (1995). https://doi.org/10.1007/BF02307079
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02307079